Sobi: Number of Shares and Votes Changes

Swedish Orphan Biovitrum AB (Sobi), a global biopharmaceutical company focused on rare diseases, announced on September 30, 2026, an adjustment to its total number of shares and votes. As of that date, the company's total share capital comprises 357,636,514 shares, all of which are common shares, with a corresponding voting power.

The increase in share count is attributed to the issuance of 223,677 class C shares. These shares were issued to fulfill commitments under the company's long-term incentive program for permanent employees. As per the company's articles of association, these class C shares have since been converted into common shares.

As of September 30, 2026, Sobi held 9,631,955 common shares in treasury. The company reported revenues of SEK 28 billion in 2025.

Sobi operates globally with approximately 2,000 employees, dedicated to transforming the lives of individuals living with rare diseases through innovative therapies. The company's shares are listed on Nasdaq Stockholm.